Losartan Cost in Iowa 2026: Cash Price, Medicaid, Insurance, and Compounding Options

What Does Losartan Actually Cost in Iowa Right Now?

Generic losartan potassium tablets cost Iowa residents approximately $10 per month at major retail chains when a GoodRx or similar discount card is applied, versus an $80 per month manufacturer list price for brand-name Cozaar. The gap between list price and actual out-of-pocket cost is dramatic for most cash-pay patients. Prices vary by pharmacy, dose, and quantity, so checking multiple dispensers before filling a prescription is a practical step.

Losartan was approved by the FDA in 1995 as Cozaar for hypertension and has been available in generic form since 2010 [1]. Because multiple manufacturers now produce the tablet, competitive pricing has pushed Iowa retail cash prices to roughly 87 percent below list price for the 50 mg once-daily formulation that most patients use for blood pressure control [2].

The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193, published in The Lancet 2002) showed losartan 50 to 100 mg daily reduced the composite of cardiovascular death, myocardial infarction, and stroke by 13 percent relative to atenolol (P<0.001), establishing it as a first-line antihypertensive [3]. That clinical track record, combined with generic availability, makes it one of the most prescribed medications in the United States, with more than 62 million prescriptions dispensed annually according to IQVIA data cited by the FDA [4].

The table below summarizes what Iowa patients typically pay at each payment channel.

| Payment channel | Estimated monthly cost (Iowa, 2026) | |---|---| | Brand Cozaar list price | $80 | | Generic cash, no card | $18 to $25 | | Generic with GoodRx/discount card | ~$10 | | Iowa Medicaid | Not covered | | Commercial insurance (Tier 1 generic) | $0 to $10 copay | | 503A compounded (telehealth programs) | $0 to $15 |

Iowa Medicaid Coverage for Losartan

Iowa Medicaid does not currently include losartan on its preferred drug list (PDL) for hypertension or heart failure in 2026. Iowa Medicaid members who need an ARB may qualify for coverage of other agents on the PDL; losartan specifically requires a prior authorization that is rarely approved without documented failure of a covered alternative [5].

Iowa Medicaid (administered through Iowa Total Care, Molina Healthcare of Iowa, and AmeriHealth Caritas Iowa as managed care organizations) follows a PDL managed by the Iowa Medicaid Drug Utilization Review program. The program applies cost-containment strategies consistent with CMS guidance on state drug coverage [6]. Patients should contact their MCO directly to confirm current formulary status, as PDLs can be updated quarterly.

For patients without Medicaid coverage of losartan, the cheapest legal routes are a GoodRx-type discount card at a retail pharmacy, enrollment in a manufacturer patient assistance program, or a telehealth prescription paired with a 503A compounding pharmacy (discussed in a later section). The American Heart Association guidelines note that ARBs, including losartan, are appropriate first-line agents for hypertension in patients who cannot tolerate ACE inhibitors, so clinical substitution is not always preferable [7].

Commercial Insurance and Losartan Formulary Tiers in Iowa

Most commercial insurance plans sold through the Iowa ACA marketplace and employer-sponsored plans in Iowa place generic losartan on Tier 1, the lowest copay tier, typically $0 to $10 per 30-day supply. Brand Cozaar, when still dispensed, usually lands on Tier 3 or Tier 4, costing $40 to $100 per month after the deductible.

The Inflation Reduction Act of 2022 capped certain Medicare Part D out-of-pocket costs beginning in 2024 and introduced a $35/month cap on insulin, but it did not establish a universal cap on antihypertensives like losartan [8]. Medicare Part D beneficiaries in Iowa with low-income subsidy (LIS / Extra Help) may pay $0 to $4.50 per fill for a Tier 1 generic.

Patients on employer-sponsored plans should review their Summary of Benefits and Coverage document for the generic drug copay tier. Iowa insurance law requires plans to include at least one ARB on formulary, per state benefit mandate reviews, though the specific agent covered varies by carrier [9].

"Patients should never assume their plan covers a specific generic simply because it is inexpensive," said the American College of Cardiology in its 2023 hypertension access guidance. "Formulary placement, prior authorization requirements, and step-therapy protocols differ substantially across payers." [10]

Is Compounded Losartan Legal in Iowa?

Compounded losartan prepared by a licensed 503A pharmacy is legal in Iowa for individual patients with a valid prescription from a licensed prescriber. Iowa Board of Pharmacy rules align with federal 503A regulations under the Drug Quality and Security Act (DQSA) of 2013 [11]. A 503A pharmacy compounds on a patient-specific basis rather than producing batches for general distribution, which is an important legal distinction.

Compounding is not the same as purchasing a commercial generic. The FDA does not evaluate compounded preparations for safety, efficacy, or manufacturing quality in the same way it reviews approved drug products [12]. Patients using compounded losartan should confirm the pharmacy holds an active Iowa Board of Pharmacy license and participates in third-party quality verification such as PCAB (Pharmacy Compounding Accreditation Board) accreditation.

503B outsourcing facilities, which produce larger batches under FDA oversight, are also a legal source, but losartan is not on FDA's current 503B bulk drug substance list, so the 503A route is the operative pathway in Iowa [13]. Some telehealth platforms that operate in Iowa bundle a compounded losartan formulation into their hypertension programs, effectively reducing the per-month medication cost to $0 when the consultation fee is the primary charge.

HealthRX Iowa Losartan Access Decision Framework

1. Does your commercial plan place generic losartan on Tier 1? If yes, your copay is likely $0 to $10. Fill at any Iowa retail pharmacy.
2. Are you on Iowa Medicaid? Losartan is not on the PDL. Ask your MCO about covered ARB alternatives or request prior authorization with documented clinical justification.
3. Are you uninsured or underinsured? Use a GoodRx card (or equivalent) at Walmart, Walgreens, Hy-Vee Pharmacy, or CVS in Iowa to access the ~$10/month cash price.
4. Is your provider a telehealth practice serving Iowa? Ask whether the platform partners with a licensed Iowa 503A pharmacy; some programs provide compounded losartan at no additional medication cost.
5. Do you meet income thresholds for Merck's patient assistance program? If yes, you may qualify for free brand Cozaar through the Merck Patient Assistance Program (application at merck.com/patient-assistance).

How to Get the Cheapest Losartan Price in Iowa

The single fastest way to reduce losartan cost in Iowa is to present a free discount card at the point of sale. GoodRx, RxSaver, NeedyMeds, and Cost Plus Drugs (Mark Cuban's pharmacy, costplusdrugs.com) each publish real-time Iowa pharmacy prices for generic losartan. Cost Plus Drugs listed losartan 50 mg (90-count) for approximately $7 as of early 2025, which translates to roughly $2.33 per tablet or about $70 for a 30-day supply at the 50 mg dose. Checking their current pricing before filling is worthwhile.

Hy-Vee Pharmacy, a regional chain dominant in Iowa, participates in most major discount card networks. Walmart's $4 generic list historically included losartan before pricing moved to per-card negotiated rates; confirm current pricing at the Altoona, Cedar Rapids, or Des Moines locations directly.

For patients who take 100 mg daily, asking the prescriber to write for losartan 100 mg tablets (rather than two 50 mg tablets) can halve the pill count and may lower cost depending on the pharmacy's per-tablet pricing structure. This is a standard pill-splitting equivalent that many Iowa prescribers already factor into their prescribing decisions [14].

The JNC 8 guideline (published in JAMA, 2014) recommended ARBs as first-line therapy for patients with chronic kidney disease or diabetes, populations in which losartan has specific FDA labeling [15]. Iowa has above-average rates of rural hypertension; the CDC reports that Iowa adults had a 35.4 percent age-adjusted hypertension prevalence in the 2021 Behavioral Risk Factor Surveillance System (BRFSS) data [16]. Cost barriers in rural areas, where pharmacy competition is lower, make discount cards especially valuable.

Telehealth Prescribing of Losartan in Iowa

Iowa law permits telehealth prescribing of losartan without an in-person physical exam, provided the prescriber establishes a valid patient-provider relationship through a synchronous audio-video encounter and documents appropriate clinical assessment. The Iowa Board of Medicine's telemedicine standards align with the American Telemedicine Association's 2021 policy guidance [17].

A telehealth visit for hypertension in Iowa typically takes 15 to 20 minutes. The prescriber reviews blood pressure readings the patient provides (home cuff readings or readings taken at a local pharmacy kiosk), medication history, and relevant lab values such as serum potassium and creatinine. Losartan can raise serum potassium and should be used with caution in patients with baseline hyperkalemia or significant renal impairment (eGFR <30 mL/min/1.73m²) [18].

Telehealth platforms operating in Iowa include HealthRX and national services such as Hims and Hers, Teladoc, and others. Prescription turnaround from a telehealth visit to pharmacy fill is typically same-day to 24 hours. Follow-up monitoring, including repeat metabolic panels at 4 to 6 weeks after starting or titrating losartan, can also be coordinated through telehealth in Iowa with orders sent to local LabCorp or Quest Diagnostics draw sites.

Clinical Profile of Losartan: Why Prescribers Choose It

Losartan blocks the angiotensin II type 1 (AT1) receptor, reducing vasoconstriction and aldosterone secretion, which lowers blood pressure and reduces cardiac and renal end-organ load. Unlike ACE inhibitors (lisinopril, enalapril), losartan does not cause cough in most patients because it does not affect bradykinin metabolism [19].

The RENAAL trial (N=1,513, NEJM 2001) showed losartan 100 mg reduced the combined endpoint of doubling of serum creatinine, ESRD, or death by 16 percent relative to placebo in patients with type 2 diabetes and nephropathy (P<0.001) [20]. The FDA approved losartan specifically for diabetic nephropathy based on this trial, making it one of the few antihypertensives with a renal-protective label in diabetes.

The LIFE trial (N=9,193, Lancet 2002) compared losartan 50 to 100 mg versus atenolol 50 to 100 mg over a mean 4.8 years. Losartan reduced fatal and nonfatal stroke by 25 percent (P<0.001) relative to atenolol despite similar blood pressure reduction, suggesting benefits beyond blood pressure lowering, particularly for patients with left ventricular hypertrophy [3].

Standard dosing for hypertension begins at 50 mg once daily, with titration to 100 mg once daily if the initial response is insufficient after 3 to 6 weeks. The FDA label states the maximum approved dose is 100 mg per day [1]. For diabetic nephropathy, the approved target is losartan 100 mg daily based on RENAAL dosing [20].

Losartan is contraindicated in pregnancy (all trimesters), and the FDA issued a Black Box Warning for fetal toxicity. Iowa prescribers counseling women of childbearing age must document this discussion and confirm contraception status [1].

Iowa Discount Programs and Patient Assistance

Several programs reduce losartan cost for Iowa residents beyond simple discount cards.

Merck Patient Assistance Program. Merck offers Cozaar (brand losartan) at no cost to eligible uninsured or underinsured patients whose income falls at or below 600 percent of the federal poverty level. Applications are submitted at merck.com or through a prescriber's office. Iowa telehealth providers can assist with documentation.

NeedyMeds. This nonprofit database (needymeds.org) lists Iowa-specific assistance programs and discount drug cards. The NeedyMeds drug card has been shown to reduce generic drug prices by 40 to 80 percent at participating Iowa pharmacies [21].

Iowa RxHelp. Iowa's state pharmaceutical assistance program does not directly cover losartan, but the Iowa Department on Aging's Benefits Enrollment Center connects residents to Extra Help (LIS) for Medicare Part D, which can reduce losartan to $0 to $4.50/month for qualifying seniors [22].

340B Program. Federally Qualified Health Centers (FQHCs) in Iowa, including UnityPoint Health's FQHC sites and community health centers in rural counties, can dispense losartan at 340B program pricing, which is substantially below retail. Iowa residents who use an FQHC as their primary care home may access losartan at negligible cost through 340B [23].

Monitoring Requirements After Starting Losartan in Iowa

Starting losartan requires baseline lab assessment and follow-up regardless of whether the prescription originates from a brick-and-mortar clinic or a telehealth visit. The standard monitoring protocol includes a basic metabolic panel (BMP) at baseline, then repeat at 4 to 6 weeks after initiation, then annually once stable. Key parameters are serum potassium (target <5.0 mEq/L), serum creatinine, and eGFR [18].

Blood pressure should be rechecked at 2 to 4 weeks after starting or dose adjustment. Most Iowa telehealth platforms issue standing lab orders for these draws and provide clinician review of results within 48 hours. Patients in rural Iowa counties with limited lab access can use mobile draw services or mail-in dried blood spot testing where available.

The 2023 ACC/AHA Hypertension Guideline Update affirmed that ARB initiation in outpatient settings is safe without hospitalization for most patients, provided baseline renal function is known and potassium is below 5.5 mEq/L before prescribing [24]. Losartan is generally well tolerated; the most common adverse effects are dizziness (4.1 percent in LIFE), upper respiratory infection symptoms, and mild fatigue. Angioedema is rare, occurring in less than 0.1 percent of ARB users compared with 0.1 to 0.7 percent for ACE inhibitors [19].

Drug interactions of note for Iowa patients: concomitant use of potassium-sparing diuretics (spironolactone, triamterene), potassium supplements, or NSAIDs (ibuprofen, naproxen) requires closer monitoring for hyperkalemia and acute kidney injury. Losartan is metabolized by CYP2C9; rifampin significantly reduces losartan plasma levels and should prompt prescriber review [1].

Comparing Losartan to Other ARBs Available in Iowa

Iowa prescribers and pharmacies stock several ARBs at competitive generic prices. Valsartan, irbesartan, and telmisartan are all available at comparable or slightly higher cash prices than losartan in Iowa. Olmesartan costs somewhat more but is Tier 1 on many Iowa commercial plans.

The choice between ARBs is often driven by formulary placement rather than clinical differentiation, as head-to-head trials show broadly similar blood pressure lowering across the class [25]. Losartan has the longest track record (FDA approved 1995) and the largest body of outcomes trial data, including LIFE and RENAAL, which is why prescribers often default to it as first-line within the ARB class.

For patients whose Iowa Medicaid plan covers valsartan or irbesartan but not losartan, switching to a covered ARB with the same mechanism is clinically reasonable and avoids out-of-pocket cost entirely. A prescriber conversation about formulary-based substitution takes under five minutes at a telehealth visit.